Latest Articles

  • Cardiovascular problems and pregnancy: An approach to management
    Samuel Siu, MD and Jack M. Colman, MD
    Cleveland Clinic Journal of Medicine December 2004, 71 (12) 977-985;

    We review the impact of pregnancy on a number of heart diseases (and vice versa) and offer recommendations for their management.

  • Benefits of more aggressive VTE prophylaxis in hospitalized medical patients
    L. Bernardo Menajovsky, MD, MS and John Spandorfer, MD
    Cleveland Clinic Journal of Medicine December 2004, 71 (12) 947-960;

    Most hospitalized medical patients who should be receiving anticoagulants to prevent VTE according to current guidelines are not getting them, or are receiving subtherapeutic doses.

  • The sad story of Vioxx, and what we should learn from it
    Juhana Karha, MD and Eric J. Topol, MD
    Cleveland Clinic Journal of Medicine December 2004, 71 (12) 933-939;

    The withdrawal of rofecoxib (Vioxx) has important implications both for patients with arthritis and for the pharmaceutical field in general.

  • A guide to assessing decision-making capacity
    Roger C. Jones, MD and Timothy Holden, MD
    Cleveland Clinic Journal of Medicine December 2004, 71 (12) 971-975;

    Physicians must care for many patients who are neither fully capable nor totally incapable of understanding and expressing choices about their treatment. We present an algorithm for assessing decision-making capacity.

  • Epidural steroids for back and leg pain: Mechanism of action and efficacy
    Epidural steroids for back and leg pain: Mechanism of action and efficacy
    Robert F. McLain, MD, Leonardo Kapural, MD, PhD and Nagy A. Mekhail, MD, PhD
    Cleveland Clinic Journal of Medicine December 2004, 71 (12) 961-970;

    Epidural steroid injections may relieve the patient’s pain while healing occurs. Who should receive this therapy, and what kind of benefit can they reasonably expect?

  • Benign prostatic hyperplasia: Now we can begin to tailor treatment
    Benign prostatic hyperplasia: Now we can begin to tailor treatment
    Carl K. Gjertson, MD, Konstantin Walmsley, MD and Steven A. Kaplan, MD
    Cleveland Clinic Journal of Medicine November 2004, 71 (11) 857-880;

    The management of benign prostatic hyperplasia has improved considerably in recent years. A review of medications, surgery, and new minimally invasive procedures.

  • The Vioxx withdrawal: Latest in the COX-2 controversies
    Brian F. Mandell, MD
    Cleveland Clinic Journal of Medicine November 2004, 71 (11) 841-842;

    Discussion of the COX-2 inhibitors has been emotionally polarized every step of the way, and it’s not over. Two other COX-2 drugs are still available, and much money is at stake.

  • Safe use of opioids in chronic noncancer pain
    Teresa E. Dews, MD and Nagy Mekhail, MD, PhD
    Cleveland Clinic Journal of Medicine November 2004, 71 (11) 897-904;

    Many physicians needlessly avoid prescribing opioid analgesics for chronic pain because of misconceptions about efficacy, adverse effects, abuse, and addiction potential.

  • Radiologic imaging in rhinosinusitis
    Pete S. Batra, MD
    Cleveland Clinic Journal of Medicine November 2004, 71 (11) 886-888;

    Imaging may be necessary for rhinosinusitis that is refractory, chronic, recurrent, or complicated.

  • A world without Vioxx: To COX-2 or not to COX-2?
    Lee S. Simon, MD and Vibeke Strand, MD
    Cleveland Clinic Journal of Medicine November 2004, 71 (11) 849-856;

    Are all selective COX-2 inhibitors associated with an increased risk for thromboembolic cardiovascular events? And what should we tell patients?

Pages